Bariatric surgery

Bariatric surgery has been studied in 487 papers since 2014: 32 trials and 144 observational studies in people, 5 in animals, 299 reviews; 236 in the past year. The newest paper, Nov 19, 2026: “Preoperative Glucagon-Like Peptide–1 Receptor Agonist Therapy and Prior Bariatric Surgery in Obese Patients Undergoing Total Knee Arthroplasty: Two Parallel National Propensity-Matched Analyses”.

Intervention

487 papers study it476 findingsUpdated

MeSH

43 new papers in 30 daysSee all 482 papers on bariatric surgery

At a glance

Human studies link bariatric surgery with lower mortality, a link independent labs report again, although other studies show no clear mortality difference; dementia associations point both ways. A human trial reports improved physical function but reduced hip bone density, while another reports lean-mass loss. Some papers declare company ties, and some authors work at companies.

476 findings in 263 papers from 2014 to 2026, 44 of them since April 2026

Independent labs found the same change in people. 124 independent labs in 41 countries.

“At < 104 weeks, MBS achieved greater reductions than GLP-1 RAs in %TWL (ETD -10.3%; p = 0.001)”
Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP-1 Receptor Agonists: A Network Meta-Analysis of Randomized Controlled TrialsObesity (Silver Spring, Md.)2025doi:10.1002/oby.70100

14 of its findings point the other way.

Humans: replicated by independent labs. Cells and mice: a single group. Worms or flies: nothing yet.
  • 124 independent labs in 41 countries
  • 14 findings against
  • Funders: National Institute of Diabetes and Digestive and Kidney Diseases and others
  • 65 of 335 findings with company ties
  • Human trial32
  • Humans142
  • Animals5
  • In silico3

24 studies gave bariatric surgery to people and measured what changed.

What changedDesignPeopleSource

down: Decreases epicardial adipose tissue volume

down: Decreases VLDL size

up: Improves HDL particle size

Trial13 peopleIn normolipidemic and normoglycemic individuals with obesityNutrition, metabolism, and cardiovascular diseases : NMCD, Jul 29, 2026

down: Decreases body weight-31.1 ± 8.7 kg, -27 %

down: Decreases resting metabolic rate-356 ± 237 kcal/day, -17 %

down: Decreases liver volume-384 ± 250 cm3, -21 %

Randomized trial26 weeks47 people39.6 ± 10.6yMidlife adults; severe obesityClinical nutrition (Edinburgh, Scotland), Mar 11, 2026

down: Decreases fat mass-32% (95% CI: -45%, -19%)

down: Decreases lean mass-15.1% (95% CI: -20.2%, -9.3%)

Treated cohort3 years (surgical groups) or 2 years (Diet group)55 peopleBoth18–70Patients with obesity undergoing four weight-loss interventionsEndocrine, Mar 9, 2026

down: Lowers the risk of obstructive sleep apnea-32.1 percentage points, 95% CI -36.9 to -27.2, p < 0.001

Trial20 years4,047 peopleIn participants with baseline OSAObesity (Silver Spring, Md.), Feb 25, 2026

down: Decreases body weight30% weight loss after surgery at 1 year

up: Increases IGFBP-2203 ng/mL (169-259) after surgery versus 153 (110-181) with LCD; P = .028

up: Increases adiponectin/leptin ratio

Trial1 year20 peopleAdultsBody mass index ≥35 kg/m2Journal of the Endocrine Society, Jan 29, 2026

What did studies of bariatric surgery find?

219

Studies of bariatric surgery measured 219 outcomes; the most studied are body weight (59 studies), mortality (15) and type 2 diabetes (13).

Body weight

downin humans55downin reviews4−20%

59 studies
  1. Bariatric surgery decreases body weight in humans (severe obesity) (-31.1 ± 8.7 kg, -27 %).

    “Significant reductions were observed in body weight (-31.1 ± 8.7 kg, -27 %), RMR (-356 ± 237 kcal/day, -17 %), kidney volume (-35.1 ± 25.2 cm3, -11 %), and liver volume (-384 ± 250 cm3, -21 %) (p < 0.01 for all)”

    Human trialsevere obesity26 weeksn = 47

    Liver and Kidney volume Reduction May Underlie Metabolic Adaptation After Metabolic Bariatric Surgery: A sub-study of the "POWER" Randomized clinical trial

    Clinical nutrition (Edinburgh, Scotland)

  2. Bariatric surgery decreases body weight in humans within 2-year postoperative period (-44 ± 13 kg).

    “Weight loss at nadir within the 2-year postoperative period was − 44 ± 13 kg (mean ± SD), while RWG was 9.2 ± 8.6 kg over the subsequent 3 years.”

    Human trialwithin 2-year postoperative period2 years

    Post-operative Metabolic Adaptation and its Influence on Long-Term Recurrent Weight Gain After Metabolic and Bariatric Surgery

    Obesity surgery

  3. Bariatric surgery decreases body weight in humans (severe obesity with sonographic evidence of MASLD) (TWL% 27.6 ± 7%).

    “By 7 ± 1 months postoperatively, the mean weight loss was 43 ± 26 kg and TWL% was 27.6 ± 7% (p < 0.001).”

    Human trialsevere obesity with sonographic evidence of MASLD7 ± 1 monthsn = 111

    The early impact of bariatric surgery on metabolic dysfunction-associated steatotic liver disease (MASLD) as assessed by fibroscan at 6 months postoperatively

    Scientific reports

  4. Bariatric surgery decreases body weight in humans (30.2% vs 14.6%, p < 0.0001).

    “At T3, there was greater %TWL after surgery compared with LCD (30.2% vs 14.6%; p < 0.0001).”

    Human trialone year

    Prospective Study of Appetitive Sensations after Metabolic and Bariatric Surgery Compared with Low-Calorie Diet

    Obesity surgery

  5. Bariatric surgery decreases body weight in humans (body mass index ≥35 kg/m2; compared with low-calorie diet) (30% weight loss after surgery at 1 year).

    “The LCD group maintained WL at T3 whereas WL was 30% after surgery.”

    Human trialbody mass index ≥35 kg/m2; compared with low-calorie diet1 year

    Greater Concentrations of IGF Binding Protein-2 after Bariatric Surgery Compared with Diet

    Journal of the Endocrine Society

  6. Bariatric surgery decreases body weight in humans (type 2 diabetes mellitus and hypertension) (-19.8%).

    “At 90 days, weight loss in the Surgery (-19.8%) and VLCD groups (-17.4%) was significant (p < 0.0001)”

    Human trialtype 2 diabetes mellitus and hypertension90 days

    Changes in Insulin Resistance with Different Weight Loss Methods in Patients with Type Two Diabetes Mellitus and Hypertension: A Comparative Clinical Trial

    Journal of clinical medicine

  7. Bariatric surgery decreases body weight in humans.

    “A statistically significant decrease and large effect size was detected for anthropometric, body composition and osteoporosis parameters (p < 0.001; d > 0.8), but also in physical strength evaluated by handgrip (p < 0.001; d = 0.75) and sit-to-stand test (p = 0.011; d = 0.46).”

    Human trial16 weeksn = 35

    The impact of bariatric surgery and exercise on systemic immune inflammation index in patients with sarcopenia obesity

    Scientific reports

  8. Bariatric surgery decreases body weight in humans.

    “SG (n = 11) and RYGB (n = 12) continued to lose weight from W11 to 1Y, whereas controls (n = 12) had regained weight.”

    Human trial1 year

    Plasma concentration of gastrointestinal hormones and subjective appetite ratings after diet or bariatric surgery: 1-year results from the DISGAP study

    International journal of obesity (2005)

  9. Bariatric surgery decreases body weight in humans (at 12 months postsurgery) (OAGB −26.7 ± 8.4%, RYGB −26.9 ± 7.3%, SG −25.1 ± 9.1%).

    “At 12 months postsurgery, patients experienced significant weight loss following all procedures (OAGB −26.7 ± 8.4%, RYGB −26.9 ± 7.3%, SG −25.1 ± 9.1%, all P <.001).”

    Human trialat 12 months postsurgery12 monthsn = 119

    One Year Changes in Body Composition and Musculoskeletal Health Following Metabolic/Bariatric Surgery

    The Journal of clinical endocrinology and metabolism

  10. Bariatric surgery decreases body weight in humans.

    “OAGB, RYGB, and SG exhibited similar reductions in body weight, body fat, and lean mass (within-group comparisons, P < .001).”

    Human trial12 months

    One Year Changes in Body Composition and Musculoskeletal Health Following Metabolic/Bariatric Surgery

    The Journal of clinical endocrinology and metabolism

All 60

Mortality

downin humans12no changein humans3HR 0.25–1.14

15 studies
  1. Bariatric surgery decreases mortality in humans (40-50% reduction).

    “biological age was markedly reduced in patients undergoing bariatric surgery resulting in a 40-50% reduction in expected mortality after two years, particularly in men”

    Human trial2 yearsn = 505

    Mortality associated biological age improves independently of weight loss after bariatric surgery

    npj aging

  2. Bariatric surgery is linked with lower mortality in patients with BMI ≥35 kg/m2 (0.46; 0.41-0.51).

    “and all-cause death (0.46; 0.41-0.51).”

    Humansin patients with BMI ≥35 kg/m24.7 years median follow-up

    Weight-loss surgery linked to lower dementia and Parkinson's risk

    International journal of obesity (2005)

  3. Bariatric surgery is linked with lower mortality in adults with SLE (1.4% vs 4.4%, p = 0.001).

    “lower CRP and ESR levels, improved eGFR, and lower mortality (1.4% vs 4.4%, p = 0.001)”

    Humansin adults with SLEfive-year follow-up

    Long-term safety and disease-modifying potential of metabolic and bariatric surgery in patients with systemic lupus erythematosus

    Surgical endoscopy

  4. Bariatric surgery is linked with lower mortality in humans (obese patients with hypertrophic cardiomyopathy) (1.2% vs. 2.9%; HR = 0.40; 95% CI: 0.27-0.61, p < 0.001).

    “BS was associated with significantly reduced all-cause mortality (1.2% vs. 2.9%; HR = 0.40; 95% CI: 0.27-0.61, p < 0.001)”

    Humansobese patients with hypertrophic cardiomyopathyup to 12 months74% females

    Cardiovascular outcomes following bariatric surgery in obese patients with hypertrophic cardiomyopathy: A multicenter propensity-matched analysis

    American heart journal plus : cardiology research and practice

  5. Bariatric surgery was not clearly linked with mortality in humans (patients operated at age over 70 years) (HR 1.14, 95% CI 0.89-1.47).

    “there was no apparent benefit in patients operated at age > 70 years (HR 1.14, 95% CI 0.89-1.47)”

    Humanspatients operated at age over 70 years

    Mortality and Causes of Death After Metabolic Bariatric Surgery in Older Patients

    Obesity surgery

  6. Bariatric surgery is linked with lower mortality in humans (obesity) (HR 0.25, 95% CI 0.08-0.77).

    “MBS was associated with a 68% reduction in all-cause mortality on univariate analysis (hazard ratio 0·32 [95% CI 0·11-0·92]; p=0·036) and a 75% reduction in all-cause mortality on multivariate analysis (0·25 [0·08-0·77]; p=0·015).”

    Humansobesity

    Metabolic and bariatric surgery in adults aged 69 years and older in England: a matched survival retrospective cohort study

    The lancet. Healthy longevity

  7. Bariatric surgery is linked with lower mortality in humans (patients with obesity, versus usual obesity care) (HR 0.77, 95% CI 0.68-0.87).

    “In total, 457 patients (22.8%) in the surgery group and 539 patients (26.4%) in the control group died (hazard ratio, 0.77; 95% confidence interval [CI], 0.68 to 0.87; P<0.001).”

    Humanspatients with obesity, versus usual obesity caremedian 24 years follow-up

    Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study

    The New England journal of medicine

  8. Bariatric surgery showed no clear effect on mortality in humans (obesity; compared with incretin receptor agonists in exploratory network meta-analysis).

    “All-cause mortality-representing the most direct and clinically relevant endpoint-did not differ significantly between the two strategies in the exploratory network meta-analysis.”

    Reviewobesity; compared with incretin receptor agonists in exploratory network meta-analysis

    Effectiveness of Bariatric Surgery and Incretin-based Therapies on Cardiovascular Outcomes in Patients with Obesity: A Systematic Review and Network Meta-Analysis

    European journal of preventive cardiology

  9. Bariatric surgery showed no clear effect on mortality in humans (obesity; compared with medical treatment in network comparisons).

    “Notably, all-cause mortality—representing the most direct and clinically relevant endpoint—did not differ significantly between the two strategies”

    Reviewobesity; compared with medical treatment in network comparisons

    Cardiovascular outcomes in obesity: bariatric surgery versus medical therapy. A network meta-analysis

    ESC Congress 2026 abstract

  10. Bariatric surgery decreases mortality in people with obesity and pre-existing cardiovascular disease (HR = 0.48, 95% CI: 0.38 to 0.61).

    “Metabolic bariatric surgery was associated with a significant reduction in ACM (HR = 0.48, 95% CI: 0.38 to 0.61, p < 0.01)”

    Reviewin people with obesity and pre-existing cardiovascular diseasen = 3,888

    Effect of Metabolic Bariatric Surgery on Cardiovascular Outcomes in People with Obesity and Pre-existing Cardiovascular Disease: A Systematic Review and Meta-Analysis

    Obesity surgery

All 15

Type 2 diabetes

downin humans13−46% remission rate

13 studies
  1. Bariatric surgery is linked with lower type 2 diabetes in humans (45.8% remission rate).

    “Diabetes remission rate was 45.8%.”

    Humansmedian follow-up 56.2 months

    Is age a real or perceived discriminator for bariatric surgery? A long-term analysis of bariatric surgery in the elderly

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  2. Bariatric surgery decreases type 2 diabetes in humans.

    “substantial improvements in type 2 diabetes, hypertension, and obstructive sleep apnea”

    Review

    Bariatric Surgery in the Elderly

    Updates in surgery/Updates in surgery series

  3. Bariatric surgery decreases type 2 diabetes in humans (PHTS diagnosis).

    “Bariatric surgery in obese patients with PHTS diagnosis results in significant decrease in weight and complete remission of diabetes mellitus type 2.”

    ReviewPHTS diagnosisfemales

    Effects of Bariatric Surgery in Individuals with PTEN Hamartoma Tumor Syndrome: A Systematic Review

    Obesity facts

  4. Bariatric surgery decreases type 2 diabetes in humans (80-98% remission rates).

    “Type 2 diabetes remission rates are high in both groups (80-98%).”

    Review

    One Anastomosis Gastric Bypass Versus Single Anastomosis Sleeve Jejunal Bypass: Does Duodenal Exclusion Matter?

    Obesity surgery

  5. Bariatric surgery decreases type 2 diabetes in humans.

    “Significant improvements are consistently observed in weight loss, type 2 diabetes control, hypertension, and functional capacity.”

    Review

    Primary Metabolic and Bariatric Surgery in Persons Aged over 65 Years. GRADE-based International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Position Statement

    Obesity surgery

  6. Bariatric surgery decreases type 2 diabetes in patients with both type 2 diabetes mellitus and obesity.

    “Bariatric surgery continues to show the most durable benefits for patients with both type 2 diabetes mellitus and obesity”

    Reviewin patients with both type 2 diabetes mellitus and obesity

    Treatment of Type 2 Diabetes in Patients with Obesity: A Review

    Endocrinology and metabolism clinics of North America

  7. Bariatric surgery decreases type 2 diabetes in humans (by introducing a negative energy balance).

    “interventions (hypocaloric diet and/or bariatric surgery), which remove ectopic fat in the liver and pancreas by introducing a negative energy balance, can normalize insulin secretion and glucose tolerance and induce the sustained biochemical remission of type 2 diabetes”

    Reviewby introducing a negative energy balance

    Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes

    International journal of molecular sciences

  8. Bariatric surgery decreases type 2 diabetes in patients with obesity.

    “Bariatric surgery is a powerful therapy for type 2 diabetes in patients with obesity.”

    Reviewin patients with obesity

    Cellular mechanism of diabetes remission by bariatric surgery

    Trends in endocrinology and metabolism: TEM

  9. Bariatric surgery decreases type 2 diabetes in humans (associated with severe obesity).

    “confirming the superiority of metabolic surgery over medical treatment for the management of type 2 diabetes associated with severe obesity.”

    Reviewassociated with severe obesity

    Surgery for Diabetes: Clinical and Mechanistic Aspects

    Canadian journal of diabetes

  10. Bariatric surgery decreases type 2 diabetes in humans (long-term).

    “These surgical procedures now emerge as the most effective therapeutic modality to induce long-term remission of type 2 diabetes.”

    Reviewlong-term

    Early Metabolic Improvement After Bariatric Surgery: The First Steps Toward Remission of Type 2 Diabetes

    Canadian journal of diabetes

All 13

More on Type 2 diabetes

Body mass index

downin humans6downin reviews1

7 studies
  1. Bariatric surgery decreases body mass index in humans (from 46.7 ± 6.1 to 32.5 ± 5.1 (P < 0.0001)).

    “Mean body mass index decreased from 46.7 ± 6.1 to 32.5 ± 5.1 (P < 0.0001)”

    Human trialat least six monthsn = 55

    Evaluation of electrocardiographic alterations before and after bariatric surgery

    Global cardiology science & practice

  2. Bariatric surgery is linked with lower body mass index in humans (compared with glp-1 receptor agonists in obese patients with hypertrophic cardiomyopathy) (-4.0 vs. -2.6 kg/m).

    “BMI reduction was greater after bariatric surgery (-4.0 vs. -2.6 kg/m; P < 0.001)”

    Humanscompared with glp-1 receptor agonists in obese patients with hypertrophic cardiomyopathy24 monthsn = 955

    Association of GLP-1 receptor agonists versus bariatric surgery with outcomes in obese patients with hypertrophic cardiomyopathy: a multicenter propensity-matched analysis

    European heart journal. Quality of care & clinical outcomes

  3. Bariatric surgery is linked with lower body mass index in adults with severe obesity and T2DM.

    “Improvements in cardiometabolic parameters, including HbA1c and BMI, were also more pronounced in the surgical group.”

    Humansin adults with severe obesity and T2DM12 monthsn = 190

    Bariatric Surgery versus Medical Management Effect on Health-Related Quality of Life in Adults with Severe Obesity and Type 2 Diabetes: A Prospective Cohort Study

    Obesity surgery

  4. Bariatric surgery is linked with lower body mass index in humans (obese patients with hypertrophic cardiomyopathy) (-5.0 kg/m2, p < 0.001).

    “BS achieved substantial BMI reduction (-5.0 kg/m2, p < 0.001).”

    Humansobese patients with hypertrophic cardiomyopathyup to 12 months74% females

    Cardiovascular outcomes following bariatric surgery in obese patients with hypertrophic cardiomyopathy: A multicenter propensity-matched analysis

    American heart journal plus : cardiology research and practice

  5. Bariatric surgery is linked with lower body mass index in humans (P < 0.001).

    “The BMI decreased within 1 year and stayed constant until a slight increase at 5 years was observed.”

    Humans5 yearsn = 62

    Opportunistic Quantitative Computed Tomography Assessing Bone Mineral Density in Patients With Laparoscopic Roux-En-Y-Gastric Bypass Metabolic Surgery Throughout a 5-Year Observation Window

    Journal of computer assisted tomography

  6. Bariatric surgery is linked with lower body mass index in humans.

    “We observed a significant decrease over time in BMI, fasting glucose, HbA1c, HOMA-IR, insulin, total cholesterol, triglycerides, LDL and free fatty acids levels”

    Humansover 12 monthsn = 40

    The effects of bariatric surgery on clinical profile, DNA methylation, and ageing in severely obese patients

    Clinical epigenetics

  7. Bariatric surgery decreases body mass index.

    “the body mass index noticeably decreases”

    Review

    Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms

    Biomolecules

More on Body mass index

Body mass index

downin humans6

6 studies
  1. Bariatric surgery decreases body mass index in humans (-11 kg/m2 (10-12.5 kg/m2)).

    “A reduction of 11 kg/m2 (10-12.5 kg/m2) was observed.”

    Human trial6 monthsfemalesn = 33

    Effect of bariatric surgery on the improvement of metabolic dysfunction associated steatotic liver disease, evaluated with elastography

    Cirugia y cirujanos

  2. Bariatric surgery decreases body mass index in humans.

    “A significant reduction in the BMI was observed during the postoperative evaluation (P < 0.0001).”

    Human trialat least six monthsn = 55

    Evaluation of electrocardiographic alterations before and after bariatric surgery

    Global cardiology science & practice

  3. Bariatric surgery is linked with lower body mass index in humans (preoperative, undergoing total knee arthroplasty) (-1.8 kg/m2).

    “The BS group achieved the largest preoperative BMI reduction (–1.8 kg/m2) vs. SU (–0.7 kg/m2) and controls (+ 2.1 kg/m2).”

    Humanspreoperative, undergoing total knee arthroplasty

    Is semaglutide a better weight-management option than bariatric surgery for patients undergoing total knee arthroplasty?

    Archives of orthopaedic and trauma surgery

  4. Bariatric surgery is linked with lower body mass index in humans (-33 kg/m2).

    “The average body mass index reduction was 33 kg/m2 (SD: 6.34).”

    Humansmean 7 yearsn = 115

    Analysis of quality of life in the medium-long term in bariatric patients using the modified BAROS system

    Cirugia y cirujanos

  5. Bariatric surgery is linked with lower body mass index in humans (morbid obesity).

    “accompanied by significant reductions in C-reactive protein (CRP), BMI and triglycerides from inclusion (p < 0.001, all).”

    Humansmorbid obesity6 and 12 months80% womensn = 110

    Changes in circulating sirtuin 1 after bariatric surgery

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  6. Bariatric surgery decreases body mass index in humans (compared with GLP-1 RAs, at 6 months, ≤1 year and >1 year) (MD -6.77 kg/m2 at 6 months; -5.10 kg/m2 at ≤1 year; -6.61 kg/m2 at >1 year).

    “BMI reduction consistently favoured BS at 6 months (MD -6.77 kg/m2; p = 0.02)”

    Reviewcompared with GLP-1 RAs, at 6 months, ≤1 year and >1 year6 months to more than 1 year

    Weight Loss Outcomes Between GLP-1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta-Analysis and Meta-Regression

    Diabetes, obesity & metabolism

Body weight

downin humans4

4 studies
  1. Bariatric surgery is linked with lower body weight in humans (20.80 ± 9.71%).

    “Mean %TWL was 20.80 ± 9.71% (n = 917) at 1 year”

    Humans1 yearn = 917

    Long-Term Weight Loss and Metabolic Outcomes After Bariatric Surgery in a Large Asian Cohort: A Real-World Cohort Study

    Obesity surgery

  2. Bariatric surgery decreases body weight in patients with obesity.

    “bariatric surgery, particularly sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), induces substantial and sustained weight loss”

    Reviewin patients with obesity

    Metabolic and Bariatric Surgery as a Strategy for Cardiovascular Risk Reduction in Obesity: A Narrative Review

    Cureus

  3. Bariatric surgery decreases body weight in humans.

    “Significant improvements are consistently observed in weight loss, type 2 diabetes control, hypertension, and functional capacity.”

    Review

    Primary Metabolic and Bariatric Surgery in Persons Aged over 65 Years. GRADE-based International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Position Statement

    Obesity surgery

  4. Bariatric surgery decreases body weight in humans.

    “Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications”

    Review

    Future therapies for obesity

    Clinical medicine (London, England)

More on Body weight

Obesity

downin humans3downin reviews1

4 studies
  1. Bariatric surgery decreases obesity in humans (severe or treatment-resistant obesity) (highly effective, durable outcomes).

    “bariatric/metabolic surgery, such as Roux-en-Y gastric bypass and sleeve gastrectomy, offers highly effective, durable outcomes”

    Reviewsevere or treatment-resistant obesity

    Swiss obesity clinical practice guidance

    Swiss medical weekly

  2. Bariatric surgery decreases obesity in obesity and associated medical problems.

    “Bariatric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy, is highly efficacious and a cost-effective treatment for obesity and associated medical problems.”

    Reviewin obesity and associated medical problems

    Endobariatric Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

    Biomedicines

  3. Bariatric surgery decreases obesity in humans.

    “Bariatric surgery as the so far most-effective therapeutic strategy”

    Review

    Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?

    Pharmacology & therapeutics

  4. Bariatric surgery decreases obesity.

    “Bariatric surgery, which can be delivered in multiple forms, has been remarked as an effective treatment to decrease the prevalence of obesity and its associated comorbidities.”

    Review

    Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms

    Biomolecules

More on Obesity

Bone mineral density

downin humans4

4 studies
  1. Bariatric surgery is linked with lower bone mineral density in humans (P < 0.001).

    “The BMD decreased substantially and continuously during 1-, 3-, and 5-year follow-up observations”

    Humans5 yearsn = 62

    Opportunistic Quantitative Computed Tomography Assessing Bone Mineral Density in Patients With Laparoscopic Roux-En-Y-Gastric Bypass Metabolic Surgery Throughout a 5-Year Observation Window

    Journal of computer assisted tomography

  2. Bariatric surgery decreases bone mineral density in humans.

    “Intentional weight loss through caloric restriction or bariatric surgery consistently accelerates bone turnover and reduces bone mineral density (BMD)”

    Review

    Beyond Weight Loss: Skeletal Considerations in Obesity Treatment

    Endocrinology and metabolism (Seoul, Korea)

  3. Bariatric surgery decreases bone mineral density in humans (obesity).

    “bariatric surgery exerts multiple adverse effects on bone tissue, characterized by significantly increased bone resorption, decreased bone mineral density (BMD)”

    Reviewobesitybone

    Impact of sleeve gastrectomy on bone metabolism in obese patients: from mechanisms to clinical prevention

    Frontiers in medicine

  4. Bariatric surgery decreases bone mineral density in humans.

    “postmenopausal women demonstrating accelerated declines in bone mineral density (BMD)”

    Reviewfemales

    Impact of Menopausal Status and Female Reproductive Aging on the Outcomes of Bariatric Surgery: A Narrative Review

    Cureus

More on Bone mineral density

Quality of life

upin humans4

4 studies
  1. Bariatric surgery is linked with better quality of life in humans.

    “Both SG and RYGB show favorable medium- to long-term outcomes in terms of weight loss, comorbidity resolution, and improved quality of life.”

    Humansmean 7 yearsn = 115

    Analysis of quality of life in the medium-long term in bariatric patients using the modified BAROS system

    Cirugia y cirujanos

  2. Bariatric surgery improves quality of life in humans (severe obesity).

    “alongside improvements in cardiometabolic health, quality of life, and psychosocial well-being”

    Reviewsevere obesity

    Obesity and its health implications: The role of metabolic and bariatric surgery in improving physical, mental, and psychosocial well-being

    International journal of obesity (2005)

  3. Bariatric surgery improves quality of life in humans.

    “bariatric surgery, promoted relevant improvements in mobility, quality of life, and sexual function”

    Review

    Obesity beyond aesthetics: mobility, sexuality, and quality of life

    Open Minds International Journal

  4. Bariatric surgery improves quality of life in post-bariatric participants (77.7 ± 15.3 vs 58 ± 16.7).

    “The QoL score was higher after surgery, ie, 77.7 ± 15.3, compared to before treatment, ie, 58 ± 16.7.”

    Reviewin post-bariatric participants

    Assessing the Impact of Bariatric Surgery on Quality of Life in the Saudi Population: A Systematic Review

    Diabetes, metabolic syndrome and obesity : targets and therapy

Fat-free mass

downin humans4

4 studies
  1. Bariatric surgery is linked with lower fat-free mass in humans (FFM from 61.1 ± 11.9 to 50.1 ± 7.0 kg (p < 0.001)).

    “and FFM to 54.7 ± 9.5 and 50.1 ± 7.0 kg (all p < 0.001). Most FFM loss occurred within the first 6 months (mean - 6.4 kg).”

    Humans12 monthsn = 179

    Body Composition Changes After Bariatric Surgery: Magnitude, Timing, and Determinants of Excessive Fat-Free Mass Loss

    Journal of clinical medicine

  2. Bariatric surgery is linked with lower fat-free mass in humans (7.8% reduction at 6 months (95% CI 7.2%-8.4%); 11.7% at 24 months).

    “Adjusted mean relative FFM reductions in the surgery group were 7.8% (95% CI, 7.2%-8.4%) at 6 months”

    Humansrelative change at 6 months, adjusted for age, sex, race, baseline BMI, diabetes history and treatment year6 monthsn = 1,257

    Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists

    JAMA network open

  3. Bariatric surgery is linked with lower fat-free mass in humans.

    “Fat free mass (FFM) was lower for BAR than for CON”

    Humansn = 100

    Sarcopenia, Muscle Mass and Protein Intake in Adults Older Than 65 Years After Earlier Bariatric Surgery

    Journal of cachexia, sarcopenia and muscle

  4. Bariatric surgery decreases fat-free mass in humans (-8.23 kg [95%CI -10.74; -5.73]).

    “FFM loss and SMM loss were -8.23 kg [95%CI -10.74; -5.73] and -3.18 kg [95%CI -5.64; -0.71], respectively.”

    Review12-month

    The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: A systematic review and meta-analysis

    Obesity reviews : an official journal of the International Association for the Study of Obesity

More on Fat-free mass

Fat mass

downin humans3−47%

3 studies
  1. Bariatric surgery decreases fat mass in humans (compared to Diet, adjusting for age and sex) (-32% (95% CI: -45%, -19%)).

    “RYGB patients achieved on average lower fat mass by 32% (95% CI: -45%, -19%) than Diet and this difference remained significant after controlling for participants’ age and sex.”

    Human trialcompared to Diet, adjusting for age and sex3 years (surgical groups) or 2 years (Diet group)

    Long-term body composition changes after bariatric surgery and their association with fat- and bone-derived hormones

    Endocrine

  2. Bariatric surgery decreases fat mass in humans (46.6%).

    “Roux-en-Y gastric bypass produced the greatest fat mass loss (46.6%)”

    Human trial36 months

    Long-term body composition changes after bariatric surgery and their association with fat- and bone-derived hormones

    Endocrine

  3. Bariatric surgery is linked with lower fat mass in humans (FM from 54.6 ± 10.7 to 22.0 ± 10.0 kg (p < 0.001)).

    “FM decreased to 35.6 ± 11.0 and 22.0 ± 10.0 kg; and FFM to 54.7 ± 9.5 and 50.1 ± 7.0 kg (all p < 0.001).”

    Humans12 monthsn = 179

    Body Composition Changes After Bariatric Surgery: Magnitude, Timing, and Determinants of Excessive Fat-Free Mass Loss

    Journal of clinical medicine

  4. Bariatric surgery is linked with lower fat mass in humans (42.4% reduction at 6 months (95% CI 41.5%-43.2%); 49.7% at 24 months).

    “Adjusted mean relative FM reductions in the surgery group were 42.4% (95% CI, 41.5%-43.2%) at 6 months”

    Humansrelative change at 6 months, adjusted for age, sex, race, baseline BMI, diabetes history and treatment year6 monthsn = 1,257

    Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists

    JAMA network open

More on Fat mass

Cognitive function

upin humans3

3 studies
  1. Bariatric surgery improves cognitive function in humans.

    “Repeated measures analysis of covariance revealed improved cognitive test scores following both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG)”

    Human trial1-monthn = 111

    Early changes in cognitive function following bariatric surgery: evidence for rapid improvement or practice effects?

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  2. Bariatric surgery improves cognitive function in humans.

    “the surgical group performed significantly better than the control group on the forward DGS, WCST, and TMT parts A and B.”

    Human trial4 monthsn = 24

    Effects of bariatric surgery on cognitive function in older adults: a prospective longitudinal study

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  3. Bariatric surgery improves cognitive function in humans (severe obesity).

    “Also, the patients presented a significant improvement in attention, mental flexibility, inhibitory control, and processing speed.”

    Human trialsevere obesity6 monthsn = 22

    Effect of bariatric surgery on neurocognitive function after 6 months of follow-up: a pilot study

    Nutricion hospitalaria

Physical function

upin humans2

2 studies
  1. Bariatric surgery improves physical function in humans (at 12 months postsurgery) (6MWT: OAGB 38.0 ± 46.5%, RYGB 24.8 ± 14.6%, SG 25.0 ± 15.0%).

    “The time taken to perform the STS test (OAGB −25.9 ± 29.0%, P =.021; RYGB −26.9 ± 17.8%, P <.001; SG −27.4 ± 20.6%, P <.001) and the distance covered during the 6MWT (OAGB 38.0 ± 46.5%, RYGB 24.8 ± 14.6%, SG 25.0 ± 15.0%, all P <.001) improved significantly at 12 months within all types of surgery, with no between-surgery differences in univariate or multivariate models”

    Human trialat 12 months postsurgery12 monthsn = 119

    One Year Changes in Body Composition and Musculoskeletal Health Following Metabolic/Bariatric Surgery

    The Journal of clinical endocrinology and metabolism

  2. Bariatric surgery improves physical function in humans.

    “Despite reductions in absolute handgrip strength, relative handgrip strength, STS test, and 6MWT improved postsurgery (all P < .02), with no differences by surgical procedure.”

    Human trial12 months

    One Year Changes in Body Composition and Musculoskeletal Health Following Metabolic/Bariatric Surgery

    The Journal of clinical endocrinology and metabolism

  3. Bariatric surgery improves physical function in humans.

    “gains in functional status and quality of life”

    Review

    Bariatric Surgery in the Elderly

    Updates in surgery/Updates in surgery series

Bone mineral density

downin humans2

2 studies
  1. Bariatric surgery decreases bone mineral density in humans (at 12 months postsurgery) (total hip: OAGB −9.6 ± 4.0%, RYGB −9.8 ± 3.9%, SG −6.5 ± 3.7%).

    “There were significant reductions in total hip (OAGB −9.6 ± 4.0%, RYGB −9.8 ± 3.9%, SG −6.5 ± 3.7%, all P <.001), femoral neck (OAGB −7.8 ± 9.2%, P =.002, RYGB −6.7 ± 6.1%, P <.001, SG −3.3 ± 7.3%, P <.001), and lumbar spine aBMD (OAGB −4.4 ± 4.9%, P =.002, RYGB −4.5 ± 4.5%, P <.001, SG −2.0 ± 3.2%, P <.001) at 12 months after all types of surgery”

    Human trialat 12 months postsurgery12 monthsn = 119

    One Year Changes in Body Composition and Musculoskeletal Health Following Metabolic/Bariatric Surgery

    The Journal of clinical endocrinology and metabolism

  2. Bariatric surgery decreases bone mineral density in humans.

    “All surgery types were associated with reductions in aBMD at the total hip, femoral neck, and lumbar spine, which were more pronounced after OAGB and RYGB than after SG (all P < .03)”

    Human trial12 months

    One Year Changes in Body Composition and Musculoskeletal Health Following Metabolic/Bariatric Surgery

    The Journal of clinical endocrinology and metabolism

  3. Bariatric surgery decreases bone mineral density in humans.

    “Both groups had decreased bone mineral density (BMD) at all sites (lumbar spine, femoral neck, and total femur) over the 1-year follow-up (p < 0.05).”

    Human trialbone1 yearfemales

    Effects of preoperative sarcopenia-related parameters on the musculoskeletal and metabolic outcomes after bariatric surgery: a one-year longitudinal study in females

    Scientific reports

Telomere length

no changein humans1upin humans1

2 studies
  1. Bariatric surgery showed no clear effect on telomere length in humans (morbid obesity) (p = 0.811).

    “relative telomere length calculated by the 2^-ΔΔCt method did not differ significantly after surgery compared with baseline values (p = 0.811).”

    Human trialmorbid obesityperipheral venous bloodone yearn = 56

    Comparison of Telomere Length Differences before and after Bariatric Surgery

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

  2. Bariatric surgery increases telomere length in humans (patients with pronounced BMI loss of >= 10 kg/m2).

    “The telomere dynamics after surgery showed an increase in mean TL in both lymphocytes and granulocytes of patients with a pronounced BMI loss of ≥ 10 kg/m2.”

    Human trialpatients with pronounced BMI loss of >= 10 kg/m2month 5.5 ± 3.9n = 35

    Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery

    Scientific reports

More on Telomere length

All 219

What is bariatric surgery linked with?

65

Studies link bariatric surgery with 65 measures, most often mortality (11 studies), cardiovascular disease (6) and bone fracture (6).

Mortality

downin humans11HR 0.48–0.76

11 studies
  1. Bariatric surgery is linked with a lower risk of mortality in humans (propensity-matched cohorts compared with GLP/GIP agonist treatment) (RR 0.561 (95% CI 0.524–0.600)).

    “Bariatric surgery was associated with significantly lower risk of mortality (RR 0.561, 95% CI: 0.524–0.600, p < 0.001)”

    Humanspropensity-matched cohorts compared with GLP/GIP agonist treatment90 to 1,095 days post-index

    Bariatric Surgery vs. GLP/GIP Agonists: A Real-World Comparative Analysis of Cardiovascular Outcomes in Over 2 Million Patients.

    AHA Scientific Sessions 2025 abstract

  2. Bariatric surgery is linked with a lower risk of mortality in humans (patients with CKD and severe obesity) (HR 0.48 (95% c.i. 0.34 to 0.67)).

    “MBS was associated with 52% lower hazards of mortality (HR 0.48 (95% c.i. 0.34 to 0.67))”

    Humanspatients with CKD and severe obesitymedian of 7.7 yearsn = 1,538

    Impact of bariatric surgery on patients with chronic kidney disease and severe obesity: multiple-linked population-based cohort study

    The British journal of surgery

  3. Bariatric surgery is linked with a lower risk of mortality in humans (severe obesity) (HR 0.76, 95% CI 0.64,0.91).

    “with a decreased risk of mortality (HR 0.76, 95% CI 0.64,0.91)”

    Humanssevere obesity

    Long-term clinical outcomes of bariatric surgery in adults with severe obesity: A population-based retrospective cohort study

    PloS one

  4. Bariatric surgery is linked with a lower risk of mortality in humans (Medicare beneficiaries with heart failure and class II obesity, propensity-matched) (HR 0.55 [95% CI 0.49-0.63]).

    “bariatric surgery was associated with lower risk of all-cause mortality (HR, 0.55 [95% CI, 0.49-0.63]; P<0.001)”

    HumansMedicare beneficiaries with heart failure and class II obesity, propensity-matchedmedian follow-up 4.7 yearsn = 2,594

    Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity

    Circulation. Heart failure

  5. Bariatric surgery is associated with mortality in humans (obese patients).

    “BS was associated with a reduction in mortality”

    Humansobese patients

    Bariatric Surgery Should Be Proposed in Certain Septuagenarian Patients with Obesity

    Obesity surgery

  6. Bariatric surgery is linked with a lower risk of mortality in humans (versus matched medically managed elderly patients with obesity).

    “There was a statistically significant decrease in the risk of death in ElderSurg (hazard ratio .584, 95% confidence interval .362-.941) compared with ElderNonSurg.”

    Humansversus matched medically managed elderly patients with obesitymedian follow-up 56.2 monthsn = 337

    Is age a real or perceived discriminator for bariatric surgery? A long-term analysis of bariatric surgery in the elderly

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  7. Bariatric surgery is associated with mortality in humans (obesity; compared with control) (HR 0.57, 95% CI 0.51–0.65).

    “Compared with control, bariatric surgery was associated with a significant reduction in all evaluated outcomes, including all-cause mortality (HR:0.57, 95%CI:0.51–0.65)”

    Reviewobesity; compared with control

    Effectiveness of Bariatric Surgery and Incretin-based Therapies on Cardiovascular Outcomes in Patients with Obesity: A Systematic Review and Network Meta-Analysis

    European journal of preventive cardiology

  8. Bariatric surgery is associated with mortality in humans (obesity; compared with control) (HR 0.56, 95% CI 0.49–0.64).

    “Compared with control, bariatric surgery significantly reduced all evaluated outcomes, including all-cause mortality (HR: 0.56, 95%CI: 0.49–0.64)”

    Reviewobesity; compared with control

    Cardiovascular outcomes in obesity: bariatric surgery versus medical therapy. A network meta-analysis

    ESC Congress 2026 abstract

  9. Bariatric surgery lowers the risk of mortality in humans (compared with conservative treatment in patients with obesity).

    “bariatric surgery is associated with lower rates of major adverse cardiovascular events (MACEs), coronary artery disease (CAD), heart failure, myocardial infarction (MI), stroke, and all-cause mortality”

    Reviewcompared with conservative treatment in patients with obesity

    Metabolic and Bariatric Surgery as a Strategy for Cardiovascular Risk Reduction in Obesity: A Narrative Review

    Cureus

  10. Bariatric surgery is associated with mortality in humans (compared with non-surgical care).

    “associated with durable weight loss and lower observed rates of MACE, heart failure and all-cause mortality compared with non-surgical care”

    Reviewcompared with non-surgical care

    Cardiovascular benefits of obesity therapies: an overview of obesity medicines and metabolic bariatric surgery

    Heart (British Cardiac Society)

All 11

Cardiovascular disease

downin humans6HR 0.55

6 studies
  1. Bariatric surgery is linked with a lower risk of cardiovascular disease in patients with BMI ≥35 kg/m2 (0.53; 0.51-0.56).

    “Similar associations were observed for CVD (0.53; 0.51-0.56);”

    Humansin patients with BMI ≥35 kg/m24.7 years median follow-up

    Weight-loss surgery linked to lower dementia and Parkinson's risk

    International journal of obesity (2005)

  2. Bariatric surgery is linked with a lower risk of cardiovascular disease in patients with diabetes.

    “This new analysis finds a reduction in risk of CVD in patients with diabetes, consistent with preexisting evidence.”

    Humansin patients with diabetes

    Long-term Cardiovascular Outcomes Following Bariatric Surgery: Reconciling Seemingly Conflicting Evidence

    Epidemiology (Cambridge, Mass.)

  3. Bariatric surgery lowers the risk of cardiovascular disease in humans (compared with conservative treatment in patients with obesity).

    “bariatric surgery is associated with lower rates of major adverse cardiovascular events (MACEs), coronary artery disease (CAD), heart failure, myocardial infarction (MI), stroke”

    Reviewcompared with conservative treatment in patients with obesity

    Metabolic and Bariatric Surgery as a Strategy for Cardiovascular Risk Reduction in Obesity: A Narrative Review

    Cureus

  4. Bariatric surgery lowers the risk of cardiovascular disease in people with obesity and pre-existing cardiovascular disease (HR = 0.55, 95% CI: 0.45 to 0.67).

    “Metabolic bariatric surgery was associated with a significant reduction in ACM (HR = 0.48, 95% CI: 0.38 to 0.61, p < 0.01) and MACE (HR = 0.55, 95% CI: 0.45 to 0.67, p < 0.01).”

    Reviewin people with obesity and pre-existing cardiovascular diseasen = 3,888

    Effect of Metabolic Bariatric Surgery on Cardiovascular Outcomes in People with Obesity and Pre-existing Cardiovascular Disease: A Systematic Review and Meta-Analysis

    Obesity surgery

  5. Bariatric surgery lowers the risk of cardiovascular disease in type 2 diabetes.

    “Bariatric surgery achieves even greater improvements in cardiovascular disease outcomes than treatments with these newer pharmacological agents.”

    Reviewin type 2 diabetes

    Hypothesis: Nutrient Off-Loading and Ectopic Fat Reduction Reverse Insulin Resistance and Improve Cardiovascular Outcomes in Type 2 Diabetes-A Narrative Review

    International journal of molecular sciences

  6. Bariatric surgery lowers the risk of cardiovascular disease in patients with obesity (RR = 0.63; 95% CI: 0.49-0.81).

    “MBS was associated with a significantly lower prevalence of CVD (RR = 0.63; 95% CI: 0.49-0.81; I2 = 87.7%)”

    Reviewin patients with obesity

    Comparing Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus Metabolic Bariatric Surgery: A Systematic Review and Meta-Analysis

    Obesity surgery

More on Cardiovascular disease

Bone fracture

upin humans6

6 studies
  1. Bariatric surgery is linked with a higher risk of bone fracture in humans (compared to medical weight management controls) (crude odds ratio of 2.71 (95% CI 1.69-4.36)).

    “The fracture rate was higher in the surgical group as compared to the controls (9.4% vs 3.5%) with a crude odds ratio of 2.71 (95% CI 1.69-4.36).”

    Humanscompared to medical weight management controls8.6 years

    Increased Fracture Risk After Bariatric Surgery: a Case-Controlled Study with a Long-Term Follow-Up

    Obesity surgery

  2. Bariatric surgery raises the risk of bone fracture in humans (obesity).

    “significantly increased bone resorption, decreased bone mineral density (BMD), and a consequent elevation in fracture risk.”

    Reviewobesitybone

    Impact of sleeve gastrectomy on bone metabolism in obese patients: from mechanisms to clinical prevention

    Frontiers in medicine

  3. Bariatric surgery raises the risk of bone fracture in humans (especially malabsorptive procedures).

    “increased risk of fracture after MBS, especially malabsorptive procedures”

    Reviewespecially malabsorptive procedures

    Effects of weight-loss interventions on bone health in people living with obesity

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

  4. Bariatric surgery raises the risk of bone fracture in humans (especially malabsorptive procedures).

    “associated with an increased risk of fracture after bariatric surgery especially malabsorptive procedures”

    Reviewespecially malabsorptive procedures

    Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity

    Calcified tissue international

  5. Bariatric surgery raises the risk of bone fracture in humans.

    “There is an increased risk of fracture after bariatric surgery.”

    Review

    French recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery

    Joint bone spine

  6. Bariatric surgery raises the risk of bone fracture in humans (21-44%).

    “Based on observational studies, bariatric surgery is associated with a 21-44% higher risk of all fractures.”

    Review

    Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)

    Bone

More on Bone fracture

Endometrial cancer

downin humans4

4 studies
  1. Bariatric surgery is associated with endometrial cancer in humans (Individuals with obesity; compared with no surgery) (aIRR 0.51, 95% CI 0.45–0.59).

    “endometrial cancer (aIRR, 0.51; 95% CI, 0.45-0.59)”

    HumansIndividuals with obesity; compared with no surgery

    Weight-loss surgery linked to lower obesity-related cancer risk

    JAMA surgery

  2. Bariatric surgery lowers the risk of endometrial cancer in humans (durable metabolic correction).

    “Bariatric surgery offers the strongest human evidence supporting the principle that durable metabolic correction can substantially reduce EC incidence.”

    Reviewdurable metabolic correction

    Metabolic Amplification in Endometrial Carcinogenesis: Biological Rationale and Translational Limits of Precision Chemoprevention

    Biomedicines

  3. Bariatric surgery lowers the risk of endometrial cancer in patients with obesity/endometrial cancer.

    “weight-loss surgery has been proven to reduce the incidence and mortality of endometrial cancer”

    Reviewin patients with obesity/endometrial cancer

    The role and effects of metabolic and bariatric surgery on endometrial cancer care

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  4. Bariatric surgery lowers the risk of endometrial cancer in humans.

    “Bariatric surgery is the gold standard for successful weight loss and highlights how reversing of the systemic effects of obesity can reduce EC risk.”

    Review

    The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches

    Biochimica et biophysica acta. Reviews on cancer

More on Endometrial cancer

Cancer

downin humans4

4 studies
  1. Bariatric surgery is linked with a lower risk of cancer in humans (obesity-associated cancers in patients with BMI ≥35 kg/m2) (0.66; 0.60-0.72).

    “obesity-associated cancers (0.66; 0.60-0.72)”

    Humansobesity-associated cancers in patients with BMI ≥35 kg/m24.7 years median follow-up

    Weight-loss surgery linked to lower dementia and Parkinson's risk

    International journal of obesity (2005)

  2. Bariatric surgery lowers the risk of cancer in humans (individuals with severe obesity).

    “associated with a reduction in overall cancer risk and cancer-related mortality, particularly for malignancies strongly linked to obesity”

    Reviewindividuals with severe obesity

    Obesity, Bariatric Surgery, and Cancer Risk: Nutritional Perspectives and Long-Term Clinical Implications

    Nutrients

  3. Bariatric surgery lowers the risk of cancer in individuals with obesity.

    “Metabolic and bariatric surgery (MBS) leads to greater maximum and sustained weight loss than nonsurgical dietary strategies and demonstrates the most convincing evidence that weight loss lowers cancer risk.”

    Reviewin individuals with obesity

    Obesity, metabolic and bariatric surgery, and cancer prevention: what do we need to learn and how do we get there?

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  4. Bariatric surgery lowers the risk of cancer in humans (severe obesity).

    “Decreases in cancer, diabetes, and cardiovascular-related mortality are major contributors to this overall effect on life expectancy after bariatric surgery”

    Reviewsevere obesity

    Resolution of Comorbidities and Impact on Longevity Following Bariatric and Metabolic Surgery

    The Surgical clinics of North America

More on Cancer

Type 2 diabetes

downin humans4−79% to −53% remission

4 studies
  1. Bariatric surgery lowers the risk of type 2 diabetes in humans (severe sarcopenic obesity) (75% remission).

    “Remission rates for comorbidities were substantial among all groups, but more marked among patients within group 1 (type 2 diabetes mellitus 75%”

    Human trialsevere sarcopenic obesity1 yearfemales

    Effects of Bariatric Surgery on Sarcopenic Obesity Outcomes: A One-Year Prospective Study in Middle-Aged Women

    Obesity surgery

  2. Bariatric surgery is linked with a lower risk of type 2 diabetes in humans (vs non-surgery) (2.6% vs 9.2%, p=0.02).

    “Incident T2D was lower (2.6% [0.5-7.4] vs 9.2% [6.7-12.2], p=0.02)”

    Humansvs non-surgery6.1 years

    Six-year Follow-Up of Nonpharmacological and Nonsurgical Obesity Treatments

    Diabetes, metabolic syndrome and obesity : targets and therapy

  3. Bariatric surgery is linked with a lower risk of type 2 diabetes in humans (severe obesity) (79.1% remission).

    “Remission occurred in 79.1% of individuals with T2DM, 36.0% with HT, 33.9% with DLP, and 79.6% with MetS.”

    Humanssevere obesity1-5 yearsn = 581

    Long-Term Metabolic Remission and Predictive Factors After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in an Asian Population

    Journal of clinical medicine

  4. Bariatric surgery is linked with a lower risk of type 2 diabetes in humans after primary laparoscopic bariatric surgery (52.8% remission).

    “Older patients had a higher prevalence of type 2 diabetes and hypertension, with remission rates of 52.8% and 40.5%, respectively”

    Humansafter primary laparoscopic bariatric surgery10 yearsn = 46

    Metabolic Bariatric Surgery in Older Patients: Is It Worth It? BARI-10-POL Study

    Obesity surgery

More on Type 2 diabetes

Heart failure

downin humans4HR 0.76

4 studies
  1. Bariatric surgery is linked with a lower risk of heart failure in humans (obese patients with hypertrophic cardiomyopathy) (8.6% vs. 10.7%; HR = 0.76; 95% CI: 0.63-0.90, p < 0.002).

    “acute heart failure hospitalization (8.6% vs. 10.7%; HR = 0.76; 95% CI: 0.63-0.90, p < 0.002)”

    Humansobese patients with hypertrophic cardiomyopathyup to 12 months74% females

    Cardiovascular outcomes following bariatric surgery in obese patients with hypertrophic cardiomyopathy: A multicenter propensity-matched analysis

    American heart journal plus : cardiology research and practice

  2. Bariatric surgery is linked with a lower risk of heart failure in adult heart transplant recipients with BMI >= 35 kg/m2 (13 vs. 24, OR 0.12, p = 0.003).

    “Heart failure rates were significantly lower in HTR/BS cohort at 1 and 3 years, but not at 5 years (13 vs. 24, OR 0.12, p = 0.003”

    Humansin adult heart transplant recipients with BMI >= 35 kg/m21 year

    The Weight of a New Heart: Bariatric Surgery after Heart Transplantation and its Clinical Impact

    Obesity surgery

  3. Bariatric surgery is linked with a lower risk of heart failure in humans (propensity-matched cohorts compared with GLP/GIP agonist treatment) (RR 0.578 (95% CI 0.531–0.630)).

    “HF (RR 0.578, 95% CI: 0.531–0.630, p < 0.001)”

    Humanspropensity-matched cohorts compared with GLP/GIP agonist treatment90 to 1,095 days post-index

    Bariatric Surgery vs. GLP/GIP Agonists: A Real-World Comparative Analysis of Cardiovascular Outcomes in Over 2 Million Patients.

    AHA Scientific Sessions 2025 abstract

  4. Bariatric surgery lowers the risk of heart failure in patients with obesity (RR = 0.50; 95% CI: 0.37-0.66).

    “and HF (RR = 0.50; 95% CI: 0.37-0.66; I2 = 70.2%) compared to GLP-1RAs.”

    Reviewin patients with obesity

    Comparing Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus Metabolic Bariatric Surgery: A Systematic Review and Meta-Analysis

    Obesity surgery

More on Heart failure

Dementia

downin humans2upin humans1HR 1.33

3 studies
  1. Bariatric surgery is linked with a lower risk of dementia in patients with BMI ≥35 kg/m2 (hazard ratio 0.48, 95% CI: 0.39-0.58).

    “individuals who underwent BS had significantly reduced incidence rates of dementia (hazard ratio 0.48, 95% CI: 0.39-0.58)”

    Humansin patients with BMI ≥35 kg/m24.7 years median follow-up

    Weight-loss surgery linked to lower dementia and Parkinson's risk

    International journal of obesity (2005)

  2. Bariatric surgery is linked with a lower risk of dementia in patients with obesity and T2D (SHR 0.60, 95% CI 0.47-0.76).

    “MBS was associated with a reduced risk of dementia (15-year cumulative incidence 1.8% vs. 2.7%, subdistribution hazard ratio [SHR] 0.60, 95% CI 0.47-0.76).”

    Humansin patients with obesity and T2D9 years

    Weight-loss surgery linked to lower dementia risk

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  3. Bariatric surgery is associated with dementia in humans (Compared with matched non-surgical subjects; adjusted for covariates) (HR 1.33; dementia incidence 1.4% versus 0.5%; p = 0.02).

    “the surgery group had a higher risk for dementia incidence than the matched non-surgery subjects (HR = 1.33, p = 0.02).”

    HumansCompared with matched non-surgical subjects; adjusted for covariatesMean follow-up of 10.5 years78% femalesn = 51,078

    Development of dementia in patients who underwent bariatric surgery

    Surgical endoscopy

More on Dementia

Atrial fibrillation

downin humans3RR 0.31–0.892

3 studies
  1. Bariatric surgery is linked with a lower risk of atrial fibrillation in humans (propensity-matched cohorts compared with GLP/GIP agonist treatment) (RR 0.892 (95% CI 0.828–0.960)).

    “Afib (RR 0.892, 95% CI: 0.828–0.960, p = 0.002)”

    Humanspropensity-matched cohorts compared with GLP/GIP agonist treatment90 to 1,095 days post-index

    Bariatric Surgery vs. GLP/GIP Agonists: A Real-World Comparative Analysis of Cardiovascular Outcomes in Over 2 Million Patients.

    AHA Scientific Sessions 2025 abstract

  2. Bariatric surgery is linked with a lower risk of atrial fibrillation in humans (Medicare beneficiaries with heart failure and class II obesity, propensity-matched) (HR 0.78 [95% CI 0.65-0.93]).

    “lower atrial fibrillation risk (HR, 0.78 [95% CI, 0.65-0.93]; P=0.006)”

    HumansMedicare beneficiaries with heart failure and class II obesity, propensity-matchedmedian follow-up 4.7 yearsn = 2,594

    Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity

    Circulation. Heart failure

  3. Bariatric surgery lowers the risk of atrial fibrillation in humans (post-ablation) (RR = 0.31 [0.13 to 0.75]).

    “Bariatric surgery was associated with reduced risk of AF recurrence (RR = 0.31 [0.13 to 0.75])”

    Reviewpost-ablation

    Comparing GLP-1 agonists versus other weight loss interventions on risk of atrial fibrillation recurrence after catheter ablation: a meta-analysis

    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

More on Atrial fibrillation

Sarcopenia

upin humans3

3 studies
  1. Bariatric surgery is linked with a higher risk of sarcopenia in humans (10 years post-surgery patients compared to 5 years).

    “while the last had enhanced sarcopenia”

    Humans10 years post-surgery patients compared to 5 years10 yearsn = 14

    Metabolic Bariatric Surgery Effects on Skeletal Muscles and Adipose Tissues

    ADA Scientific Sessions 2025 abstract

  2. Bariatric surgery raises the risk of sarcopenia in humans.

    “This narrative review synthesizes contemporary evidence on late complications across procedures, including nutritional and mineral deficiencies, sarcopenia, bone health disorders, dumping syndrome, nephrolithiasis, and mental health outcomes”

    Review

    A Contemporary Perspective on Long-Term Complications of Bariatric Surgery

    Obesity surgery

  3. Bariatric surgery raises the risk of sarcopenia in humans.

    “However, it is not risk-free, especially in a vulnerable population, predisposing to falls, fractures and sarcopenia.”

    Review

    Sheer drop ahead: reviewing sarcopenia outcomes in elderly patients undergoing bariatric surgery

    Reviews in endocrine & metabolic disorders

More on Sarcopenia

Obstructive sleep apnea

downin humans1

1 study
  1. Bariatric surgery lowers the risk of obstructive sleep apnea in participants with baseline OSA (-32.1 percentage points, 95% CI -36.9 to -27.2, p < 0.001).

    “bariatric surgery was associated with a 32.1 percentage points lower prevalence of OSA in participants with baseline OSA (95% CI: -36.9 to -27.2; p < 0.001) compared to usual care”

    Human trialin participants with baseline OSA20 years

    Obstructive Sleep Apnea Following Bariatric Surgery: 20 Year Outcomes From the Swedish Obese Subjects Study

    Obesity (Silver Spring, Md.)

More on Obstructive sleep apnea

Circulating proteome

mixedin humans1

1 study
  1. Bariatric surgery is associated with circulating proteome in humans (23 proteins).

    “Twenty-three proteins were altered in a consistent direction after both bariatric surgery and caloric restriction”

    Human trial

    Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome

    Scientific reports

More on Circulating proteome

All 65

Funding

26 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$9.2MNational Heart, Lung, and Blood Institute$4.5MNational Institute for Health Research£2.6M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human cohorts link bariatric surgery with lower mortality in people with obesity, a pattern reported by independent labs; other reports show no clear mortality or cardiovascular association. Human trials report improved physical function but decreased hip bone density and lean mass. Some papers declare ties to Novo Nordisk and AstraZeneca.

  2. Summary rewritten as its findings changed.

    As it read before

    Independent human studies associate bariatric surgery with lower mortality in obesity; cohorts also report lower cardiovascular risk, although other studies report no change in either outcome. Telomeres lengthen across independent labs but remain unchanged in other studies; human trials report improved physical function alongside reduced bone density and lean mass. Some papers declare company ties.

  3. Summary rewritten as its findings changed.

    As it read before

    Bariatric surgery is associated with lower mortality and dementia risk in human studies of people with obesity. Independent labs report telomere lengthening, but other studies report no telomere or epigenetic-age change; long-term follow-up also reports increased fracture risk. Some papers declare ties to Amgen, Abbott, AstraZeneca, and other companies.

  4. Summary rewritten as its findings changed.

    As it read before

    A human study reports lower liver stiffness and controlled attenuation parameter after bariatric surgery in obesity with MASLD; another reports reduced AI-ECG age gap after the first postoperative year. Reviews describe weight loss and lower cardiovascular risks in obesity.

  5. Summary written from the findings.

Latest

Dec 2025: 11Jan 2026: 39Feb 2026: 41Mar 2026: 34Apr 2026: 7May 2026: 9Jun 2026: 10Jul 2026: 11Aug 2026: 5Sep 2026: 12Oct 2026: 27Nov 2026: 22228 papers in 12 months

See all 482 papers on bariatric surgery